Kouji Okada

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Venues

PCN reports : psychiatry and clinical neurosciences

Psychiatry and clinical neurosciences

Journal of pharmaceutical health care and sciences

Pharmacy (Basel, Switzerland)

Kanazawa University (BSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Kanazawa University Apr 01 1991 - Mar 31 1996

Japan

BSC :: Faculty of Pharmacy and Pharmaceutical Sciences

Publications

Daisuke Kikuchi, Taku Obara, Ryo Obara, Hiroaki Hino, Naoto Suzuki, Shota Kashiwagura, Takashi Watanabe, Ryusuke Ouchi, Kensuke Usui, Kouji Okada
Temporal trends in antipsychotic prescriptions for pediatric patients using an administrative hospital database in Japan: a retrospective study. Journal of pharmaceutical health care and sciences 10 (1) (2024)
Daisuke Kikuchi, Taku Obara, Ryo Obara, Hiroaki Hino, Naoto Suzuki, Shota Kashiwagura, Takashi Watanabe, Ryusuke Ouchi, Kensuke Usui, Kouji Okada
Temporal trends in antipsychotic prescriptions for pediatric patients using an administrative hospital database in Japan: a retrospective study. Journal of pharmaceutical health care and sciences 10 (1) (2024)
Go Anan, Daisuke Kikuchi, Kenji Omae, Takuo Hirose, Kouji Okada, Takefumi Mori
Sodium-glucose cotransporter-2 inhibitors increase urinary tract infections?-a cross sectional analysis of a nationwide Japanese claims database. Endocrine journal (2023)
Kensuke Usui, Daisuke Kikuchi, Noa Otsuka, Kouta Miyagi, Ryusuke Ouchi, Takashi Watanabe, Kouji Okada, Eiji Suzuki
Hypnotic prescriptions in Japan may be shifting from benzodiazepine receptor agonists to other types of hypnotics, melatonin receptor agonists, and orexin receptor antagonists. PCN reports : psychiatry and clinical neurosciences 2 (2) (2023)
Kensuke Usui, Daisuke Kikuchi, Noa Otsuka, Kouta Miyagi, Ryusuke Ouchi, Takashi Watanabe, Kouji Okada, Eiji Suzuki
Hypnotic prescriptions in Japan may be shifting from benzodiazepine receptor agonists to other types of hypnotics, melatonin receptor agonists, and orexin receptor antagonists. PCN reports : psychiatry and clinical neurosciences 2 (2) (2023)
Kensuke Usui, Yu Fujii, Kouji Okada, Eiji Suzuki
Low-dose benzodiazepine receptor agonists may be completely replaced by lemborexant at about the same dose. PCN reports : psychiatry and clinical neurosciences 1 (3) (2022)
Daisuke Kikuchi, Taku Obara, Aoi Noda, Gen Oyanagi, Mami Ishikuro, Kouji Okada, Nariyasu Mano
Assessment of Information Sharing on Adverse Drug Reactions by Community Pharmacies with Other Medical Institutions. Pharmacy (Basel, Switzerland) 10 (1) (2022)
Kensuke Usui, Yu Fujii, Kouji Okada, Eiji Suzuki
Low-dose benzodiazepine receptor agonists may be completely replaced by lemborexant at about the same dose. PCN reports : psychiatry and clinical neurosciences 1 (3) (2022)
Shota Kashiwagura, Yasuhiro Kamioka, Masafumi Seki, Satoshi Koshika, Kouji Okada
Analysis of Risk Factors Associated with Reduced Trough Concentrations of Vancomycin in Relation to Renal Function in a Tertiary Hospital in Japan. Infection and drug resistance 14 (2021)
Kouji Okada, Kazuo Yamada, Kensuke Usui, Ryusuke Ouchi, Masashi Nibuya, Ai Takahashi, Yuzo Shito, Yoshiteru Watanabe, Eiji Suzuki
Inadequate therapeutic drug monitoring in patients with lithium toxicity in Japan. Psychiatry and clinical neurosciences 74 (11) (2020)
Kouji Okada, Takashi Uno, Miho Utsumi, Kensuke Usui, Masashi Nakamura, Ichiro Nakashima, Eiji Suzuki, Yoshiteru Watanabe
Amantadine intoxication despite moderate renal dysfunction: A case of combined use with donepezil. Clinical case reports 8 (6) (2020)
Kouji Okada, Kensuke Usui, Daisuke Kikuchi, Masanori Takahashi, Yoshiteru Watanabe
The risk of nephrotic syndrome with non-VEGF inhibitory antineoplastic drugs: from viewpoint of the adverse event reports in Japan. Clinical and experimental nephrology 25 (1) (2020)
Kensuke Usui, Kazuo Yamada, Kouji Okada, Ryusuke Ouchi, Masashi Nibuya, Ai Takahashi, Yuzo Shito, Yoshiteru Watanabe, Hidehisa Saeki, Eiji Suzuki
Changes in ratio of ineligible use of lamotrigine in Japan based on data from the relief system of the Pharmaceuticals and Medical Devices Agency. Psychiatry and clinical neurosciences 75 (1) (2020)

Kouji Okada.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kouji Okada